Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Hypertension. 2009 Dec 28;55(2):207–213. doi: 10.1161/HYPERTENSIONAHA.109.140145

Table.

Summarized phenotypic and the main changes in the RAS observed in some animal models of deficiency or overexpression of ACE2 and Mas.

Strategy Strain Changes in RAS Phenotype Reference
ACE2 overexpression in smooth muscle cells SHRSP ↑aortic ACE2 activity Improved endothelial function Rentzsch et al19
↑Ang-(1-7) plasma/aorta
↑Ang-(1-7)/Ang II
Lentiviral ACE2 gene transfer in hearts SHR ↑cardiac ACE2 mRNA BP independent cardioprotection Diez-Freire et al16
↑cardiac ACE2 activity
ACE2 overexpression in hearts FVB/NTac ↑serum ACE2 activity Cardiac rhythm disturbances and sudden death Donoghue et al11
↑cardiac ACE2 expression
Adenoviral ACE2 gene transfer in hearts SHRSP ↑cardiac ACE2 activity Severe cardiac fibrosis Masson et al22
↑Ang-(1-7) expression
↓ACE activity
ACE2 knockout Mixed background ↑cardiac/plasma/renal Ang II ↓BP and impaired systolic function Crackower et al8
ACE2 knockout Mixed background No basal changes Variable Gurley et al12
ACE2 knockout Mixed background No basal changes No basal changes Yamamoto et al61
Mas knockout C57BL/6 ↓Ang-(1-7) binding in cardiac myocytes Impaired heart function and cardiac fibrosis Santos et al13
Mas knockout C57BL/6 Not determined ↑sympathetic tonus Walther et al62
Mas knockout C57BL/6 Not determined Impaired Ang-(1-7)-mediated aortic relaxation Peiró et al63
Mas knockout FVB/N Not determined ↑BP, impaired endothelial function and ↓NO and eNOS Xu et al64